Member Info for ABftse

I can see this going to 10p / April 2020 levels.

When TUI placed shares it was easy and straightforward to buy, with plenty of time given.

I'm finding Valirx to be totally the opposite. If you buy on open market, you'll pay 10% more than the likes of Adam and Nick, who I would imagine are buying.

Is anyone buying in the placing (10p share)?

We should also expect results on these '4' tCROs they want to buy. Do they have any companies in mind? Why four?
Where did the expected revenues of £10mln within 5 yrs come from?
I expected tangible plans.

OB,
We should give TRX 6 weeks max. Another licencing would take months to arrange even before they start fundraising.

crl123
No worries and all the best. Take care.
AB

I only suggested putting your money in your bank or Valirx. It was not 'investment advice'.

Many of the so called helpful people here could be shorting (short selling) Valirx - so they want the share price to fall. I very clearly stated I was invested in Valirx so therefore biased.

It was only Friday morning that I looked into investing in 4D but found out the following:
1. It had made loses of between £24.3 million and £70.48 million every year since 2017!
2. Those losses increased every year. They lost £70.48 million in y/e 2021.
3. Their annual revenue was between £210,000 and £520,000 for the last three years. Tiny!
Plus, they had a £13.9 million loan. So, yes, not great.

What did they spend all that money on?

But I read all that and invested in Valirx instead.

I also looked into the science at 4D and nothing impressed me. A treatment for IBS was one of them. Valirx have a licence from Cancer Research UK (Cancer Research Technologies) for a prostate cancer therapy. They have links with Universities.

I am a long term investor so I plan to hold Valirx for at least 6 months. It could go either way in the short term, but it is promising in the long term. We will see. But please, if anyone comments on Valirx please state whether you are short selling Valirx or long (like me). It is more honest that way.

crl123

At least you still have the other 1/4 left. Stick that in an index fund (e.g. S&P 500, etc) and that should compound its way nicely up to retirement.

Anyone think 4d assets (labs and IP?) might be good for ValiRx ?

Also - the deadline to vote is today!

I was pondering whether to invest into 4d or Valirx today

I invested in Valirx instead. So lucky.

But feel for everyone here.

Good for you , ells_valexpert
Maybe another bite of the cherry?
To answer your q, DDDD had massive debts / highly geared.
Valirx does not.

crl123.
Don't worry as long as you have life and health. There is always a level or risk with any investment. We never know the full story behind any company. Try and move and stay positive.

Friday evening admin - probably timed for after the staff have left for the weekend. I'm sure administrators will be itemising everything over the weekend.

4d (DDDD) going into Administration is big sector news.

Was anyone invested in 4d?

Could ValiRx buy some of their assets - e.g. labs etc?
Suzy did want to open a Transitional Contract Research Organisation (tCRO)

Not looking good over at 4d - DDDD.

Why have they suspended trading?

The company have NOT stated why other than that "A further announcement will be made as soon as practicable."

That is not on.

*Triple Negative Breast Cancer news.

You have retail investors who have sold at massive losses when the situation is likely to improve in a few days/weeks. But then you have the serious investors like Adam and Nick who are here to stay. They haven't sold a single share. The retail investors have sold at large losses out of fear, even when there is Triple Breast Cancer news around the corner and VAL201. Yes, a delay is likely for VAL201 but that is not surprising given the economic climate. Patience!

Doubt they would pay £4m for a lab - and they certainly wouldn't raise £4m when a target hasn't even been identified, that we know of.

"they could buy a lab part cash/shares or part debt for probably up to £4m value."
Where did £4m value come from?

People behind TheoremRx will lose credibility if they don't achieve funding. Cancer Research UK therapy after all.